Walid Harb Georgio Chidiac Georges Harb
10.4103/meajo.MEAJO_297_19
Middle East Afr J Ophthalmol
2021 Apr 30;28(1):18-22.
aflibercept combination therapy dexamethasone macular edema retinal vein occlusion
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/34321818/
Angiogenesis Inhibitors / administration & dosage Dexamethasone / administration & dosage Macular Edema / diagnosis Macular Edema / drug therapy Macular Edema / etiology Receptors, Vascular Endothelial Growth Factor / administration & dosage Recombinant Fusion Proteins / administration & dosage Retinal Vein Occlusion / complications Retinal Vein Occlusion / drug therapy
Angiogenesis Inhibitors / administration & dosage Dexamethasone / administration & dosage Macular Edema / diagnosis Macular Edema / drug therapy Macular Edema / etiology Receptors, Vascular Endothelial Growth Factor / administration & dosage Recombinant Fusion Proteins / administration & dosage Retinal Vein Occlusion / complications Retinal Vein Occlusion / drug therapy Aged Aged, 80 and over Drug Implants / therapeutic use Female Glucocorticoids / therapeutic use Humans Intravitreal Injections Male Middle Aged Prospective Studies Tomography, Optical Coherence Angiogenesis Inhibitors Drug Implants Glucocorticoids Recombinant Fusion Proteins aflibercept Dexamethasone Receptors, Vascular Endothelial Growth Factor
PMC8270014
34321818
Outcomes of Combination Therapy using Aflibercept and Dexamethasone Intravitreal Implant versus Dexamethasone Monotherapy for Macular Edema Secondary to Retinal Vein Occlusion
2021